SDIC Fund Leads $66M Round In Chinese Respiratory Drug Developer CF PharmaTech Aug 28, 2017 Life Science
aTyr Pharma, a US-Hong Kong Biotech, Announces $46 Million Private Placement Aug 28, 2017 Life Science
Zhejiang Hisun Partners with Seattle’s IDRI on Treatment for Drug-Resistant TB Aug 26, 2017 Life Science
RedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release Capsules Aug 18, 2017 Life Science
Harbin Gloria, WuXi Biologics Sign $818 Million Deal for Ex-China Rights to PD-1 Candidate Aug 17, 2017 Life Science
